Connect With Us

Inside INdiana Business
Subscribe Now Log In
  • Home
  • News
    • Education
    • Health
    • Tech
    • STEM
    • Advanced Manufacturing & Logistics
    • Life Sciences
    • Ag INnovation
    • INPower
  • Videos
  • Big Wigs
    • Submit Big Wigs
  • Events
    • Engage Southwest Indiana – Evansville
    • Engage Northwest Indiana – Valparaiso
    • Engage Greater Lafayette – West Lafayette
    • Engage West Central Indiana – Terre Haute
    • Engage South Bend – Elkhart
    • Engage Northeast Indiana – Fort Wayne
    • Engage Central Indiana – Indianapolis
  • Newsletters
  • Podcasts
  • On-Air
    • TV & Radio Listings
  • Contact
    • About IIB
    • Meet the Team
    • Contact Us
    • Advertise
    • Gift Cards
    • Flagship Stations
    • Gerry’s Message
    • Speaking Engagement Request

Connect With Us

Hoosier Life Sciences Sector Accesses $9.1B in Capital

Wednesday, April 22, 2020 04:59 PM EDT Updated: Wednesday, April 22, 2020 05:22 PM EDT
By Alex Brown
Hoosier Life Sciences Sector Accesses $9.1B in Capital

Indiana’s life sciences companies were the recipients of major amounts of capital in 2019. A new report from BioCrossroads says businesses in the sector accessed $9.1 billion in capital last year from a variety of sources. 

The state’s life sciences initiative $8.6 million in Small Business Innovation Research grants were awarded to 21 companies. Meanwhile, 37 companies received $177 million in venture capital investments, while nearly $179 million was access through public markets by two companies.

Additionally, more than $8.7 billion was spent among eight transactions to acquire innovation.

“Having access to multiple capital investment vehicles fuels Indiana’s diverse and vibrant life sciences industry, which adds to the strength of the sector. There is a lot to be excited about, and more work to do,” said Nora Doherty, Indiana Seed Fund managing director for BioCrossroads and author of the report. “Our innovators, those who support the development of their ideas, as well as those that provide capital to fuel discovery and development, are all critical components to bringing new medical therapeutics and devices to market.”

BioCrossroads says life sciences companies also raised more than $360 million, excluding funding represented by mergers and acquisitions. The funding, according to the organization, supports innovation to discover and develop new therapies for diseases.

This is the first year BioCrossroads has compiled the data for this type of report. You can view the full report by clicking here or in the document below:
 

 

Story Continues Below

Most Popular Stories

  • Vanderburgh commissioners to vote on rezoning for disputed Love’s Travel Stop

  • OpenLane to expand Canadian presence with $95M acquisition

  • Q&A with co-owners of Patoka Lake Marina and Winery

  • Armstrong named next CEO of Child Advocates

  • Notre Dame buys former South Bend Tribune offices

  • State files to dismiss legal challenge to law enforcement ‘buffer zone’

Perspectives

Grow your business: Learn from failure

Grow your business: Learn from failure

Basketball phenom Steph Curry of the Golden State Warriors is no stranger to losing, much less failure, even though he is one of the most successful professional basketball players of today. His record-breaking career has had countless ups and downs....

Inside INdiana Business

Inside INdiana Business
A division of IBJ Media

1 Monument Circle, Suite 300
Indianapolis, IN 46204

PHONE: (317) 634-6200

FAX: (317) 263-5060

NEWSLETTER@IIBNEWS.COM

  • Home
  • News
  • Videos
  • Gerry Dick
  • Newsletters
  • On-Air
  • Contact

Copyright © 2023 All Rights Reserved Privacy Policy | Terms of Service